Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers C > Headlines for CV Therapeutics Inc. > News item |
CV Therapeutics repurchases $14.9 million of its convertibles
By Devika Patel
Knoxville, Tenn., Nov. 6 - CV Therapeutics Inc. said it bought back $14.9 million of its convertible subordinated notes in the third quarter of 2008.
The notes were bought back for $14.2 million.
CV Therapeutics is a biopharmaceutical company based in Palo Alto, Calif.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.